Safe for babies: FDA has no objections to GRAS status of Ganeden's BC30 probiotic strain for use in infant formula
The FDA has no objections to Ganeden BC30s GRAS status for use in infant formulas, the company announced this week.
Archives for January 20, 2017
Asia growth: The main reason Nestle could be keen on Mead Johnson acquisition
The financial press is rife with chatter that Nestle is weighing up a bid for US infant formula firm Mead Johnson.